LivaNova PLC (NASDAQ:LIVN) was upgraded by equities research analysts at Needham & Company LLC from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday. The brokerage currently has a $83.00 price target on the stock. Needham & Company LLC’s price objective would indicate a potential upside of 21.93% from the company’s current price.

Several other equities research analysts have also recently commented on the company. Piper Jaffray Companies restated an “overweight” rating and issued a $75.00 target price on shares of LivaNova PLC in a research note on Tuesday. Jefferies Group LLC began coverage on LivaNova PLC in a research note on Friday, September 8th. They issued a “buy” rating and a $76.00 target price on the stock. WBB Securities cut LivaNova PLC from a “hold” rating to a “sell” rating and set a $50.00 target price on the stock. in a research note on Tuesday, August 15th. Berenberg Bank restated a “buy” rating and issued a $70.00 target price on shares of LivaNova PLC in a research note on Friday, August 11th. Finally, BidaskClub cut LivaNova PLC from a “buy” rating to a “hold” rating in a research note on Tuesday, August 1st. One analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $68.00.

LivaNova PLC (NASDAQ:LIVN) opened at 68.07 on Friday. The firm has a market cap of $3.32 billion, a P/E ratio of 121.55 and a beta of 0.58. The company has a 50-day moving average price of $62.35 and a 200-day moving average price of $57.45. LivaNova PLC has a 12-month low of $40.83 and a 12-month high of $68.15.

LivaNova PLC (NASDAQ:LIVN) last released its earnings results on Wednesday, August 9th. The company reported $1.01 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.82 by $0.19. The firm had revenue of $321.40 million for the quarter, compared to analysts’ expectations of $315.75 million. LivaNova PLC had a return on equity of 9.08% and a net margin of 2.26%. The company’s revenue was up .1% compared to the same quarter last year. On average, analysts predict that LivaNova PLC will post $3.24 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/09/15/livanova-plc-livn-upgraded-at-needham-company-llc.html.

In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $60.76, for a total transaction of $60,760.00. Following the sale, the director now owns 58,296 shares in the company, valued at approximately $3,542,064.96. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 0.28% of the company’s stock.

Institutional investors have recently made changes to their positions in the company. PNC Financial Services Group Inc. raised its stake in shares of LivaNova PLC by 9.8% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock worth $105,000 after purchasing an additional 153 shares in the last quarter. Riverhead Capital Management LLC raised its stake in shares of LivaNova PLC by 76.3% during the 2nd quarter. Riverhead Capital Management LLC now owns 1,763 shares of the company’s stock worth $108,000 after purchasing an additional 763 shares in the last quarter. Meadow Creek Investment Management LLC raised its stake in shares of LivaNova PLC by 11.4% during the 1st quarter. Meadow Creek Investment Management LLC now owns 2,464 shares of the company’s stock worth $121,000 after purchasing an additional 252 shares in the last quarter. Glen Harbor Capital Management LLC raised its stake in shares of LivaNova PLC by 11.4% during the 1st quarter. Glen Harbor Capital Management LLC now owns 2,992 shares of the company’s stock worth $147,000 after purchasing an additional 306 shares in the last quarter. Finally, Exane Derivatives raised its stake in shares of LivaNova PLC by 814.8% during the 2nd quarter. Exane Derivatives now owns 3,156 shares of the company’s stock worth $158,000 after purchasing an additional 2,811 shares in the last quarter. Institutional investors own 82.36% of the company’s stock.

About LivaNova PLC

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Analyst Recommendations for LivaNova PLC (NASDAQ:LIVN)

Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.